One Person Shot at a garage on Allen St. in New Britain
Shop owner’s bother in law was shot by one of the three masked men who demanded money.
The individual who was shot is expected to make full recovery.
This occurred shortly after ten AM and the police are asking for anyone with information about this incident to please call the detective bureau at 826-3065
Monday, June 15, 2009
Meriden Co. Manufactures 1st H1N1 Vaccine
PSC Able To Produce 100,000 Doses Per Week, Officials Say
POSTED: 2:00 pm EDT June 15, 2009
MERIDEN, Conn. -- A Meriden biopharmaceutical company has begun manufacturing a vaccine to protect people from the H1N1 flu virus .
The company, Protein Sciences Corp., said the vaccine is called PanBlok.
The vaccine is created using proprietary baculovirus and insect cell manufacturing technology.
PSC officials said they believe the vaccine is the only vaccine that could be used to protect against the escalating worldwide pandemic, at least for the next few months.
Protein Sciences Corp. said it's able to produce 100,000 doses of the vaccine each week.
However, following bulk production, officials said, the vaccine will undergo routine quality tests, the longest of which will require up to one month, officials said. Mid-July, they said, the vaccine should be ready for use in clinical trials and/or for vaccinations in countries that grant regulatory clearance.
"We are in the process of transferring our proprietary manufacturing technology to facilities in other countries and we are setting up a foundation to ensure vaccine availability for U.N. member countries consistent with the commitment we made to the World Health Organization and the United Nations in Geneva, Switzerland on May 19, 2009." Said Daniel Adams, chairman, president and CEO of the company said.
PSC also announced that it will begin shipping H1N1 protein for research use to customers with pre-orders. Orders can be placed on the company's Web site.
PSC is in talks with various parties in the U.S. and abroad to conduct the first human clinical trials of an H1N1 vaccine, officials said. Such studies will evaluate different doses, two dosing regimes and an adjuvanted formulation of the vaccine.
E-mail news tips to Eyewitness News, or dial: 866-289-0333.
Connecticut's latest breaking news is on WFSB.com and Channel 3 Eyewitness News.
Be The First To Know: Breaking News, Weather, Sports E-mail From WFSB.com Weekdays
POSTED: 2:00 pm EDT June 15, 2009
MERIDEN, Conn. -- A Meriden biopharmaceutical company has begun manufacturing a vaccine to protect people from the H1N1 flu virus .
The company, Protein Sciences Corp., said the vaccine is called PanBlok.
The vaccine is created using proprietary baculovirus and insect cell manufacturing technology.
PSC officials said they believe the vaccine is the only vaccine that could be used to protect against the escalating worldwide pandemic, at least for the next few months.
Protein Sciences Corp. said it's able to produce 100,000 doses of the vaccine each week.
However, following bulk production, officials said, the vaccine will undergo routine quality tests, the longest of which will require up to one month, officials said. Mid-July, they said, the vaccine should be ready for use in clinical trials and/or for vaccinations in countries that grant regulatory clearance.
"We are in the process of transferring our proprietary manufacturing technology to facilities in other countries and we are setting up a foundation to ensure vaccine availability for U.N. member countries consistent with the commitment we made to the World Health Organization and the United Nations in Geneva, Switzerland on May 19, 2009." Said Daniel Adams, chairman, president and CEO of the company said.
PSC also announced that it will begin shipping H1N1 protein for research use to customers with pre-orders. Orders can be placed on the company's Web site.
PSC is in talks with various parties in the U.S. and abroad to conduct the first human clinical trials of an H1N1 vaccine, officials said. Such studies will evaluate different doses, two dosing regimes and an adjuvanted formulation of the vaccine.
E-mail news tips to Eyewitness News, or dial: 866-289-0333.
Connecticut's latest breaking news is on WFSB.com and Channel 3 Eyewitness News.
Be The First To Know: Breaking News, Weather, Sports E-mail From WFSB.com Weekdays
600 Protest Pelosi in Houston
Speaker of the House Nancy Pelosi was greated by an angry mob of protestors on June 12th as she attempted to address a much smaller crowd of her supporters in Houston, Texas. Click the headline above to check out a video of the protest.
Sunday, June 14, 2009
Saturday, June 13, 2009
TAXPAYERS SHOULD DUMP ANOTHER DODD

Letter to The Editor:
It doesn’t require the brightest crayola in the box to understand why Christopher Dodd is a liar, a fraud and a betrayal of the public trust. The apples rarely fall far from the tree. The recent passing of Michael O’Hare brings to mind the deceit, the fraud and the betrayal of the public trust of his father, Thomas Dodd. Thomas Dodd’s use of campaign funds for his personal expenses is well documented. His acceptance of a $50,000.00 bribe (Dodd claimed to be a lobbyist) from the Guatemalan dictator Armas and his insistence that the Federal government extend a quid pro quo payment to the Guatemalan government of $15,000,000.00 is shameful and despicable even when measured by today’s standards. Thomas Dodd and Carlos Armas and Christopher Dodd and Fidel Castro like father like son. Thomas Dodd lifted the text of NAZI gun control laws and embedded its concept into the US Gun Control Act of 1968. In their thoroughly researched papers Aaron Zelmon and Neal Knox expose Thomas Dodd’s NAZI connection. Thomas Dodd was censured by the US Senate and rightfully defeated by the voters of Connecticut. Now, it is most unlikely that Christopher Dodd will be censured by his cowardly Democrat cronies in the Senate. This writer hopes that the honest, hard working and taxpaying residents of this state will oust Christopher Dodd from the Senate just as they bounced Thomas Dodd forty years ago.
Submitted by Richard R. Rotella
Friday, June 12, 2009
Subscribe to:
Posts (Atom)

.jpg)











